drugset / Trial / NCT04459273

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273 ↗

Phase 1 Active not recruiting 26 enrolled Jonsson Comprehensive Cancer Center
NaSingle-groupOpen-labelBasic science

Summary

This exploratory study investigates how an imaging technique called 68Ga-FAPi-46 PET/CT can determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues in patients with cancer. Because some cancers take up 68Ga-FAPi-46 it can be seen with PET. FAP stands for Fibroblast Activation Protein. FAP is produced by cells that surround tumors (cancer associated fibroblasts). The function of FAP is not well understood but imaging studies have shown that FAP can be detected with FAPI PET/CT. Imaging FAP with FAPI PET/CT may in the future provide additional information about various cancers.

Timeline

Start
2020-08-27
Primary completion
2025-06-24
Completion
2027-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject FAPI-46 GA-68 Diagnostic / imaging agent — Intravenous